Search research articles
Contact Us
Filters
Showing results (211-220 of 232) with videos related to
Page
of 24
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
September 16, 2009
Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique
Raymond S Douglas, Angelo Tsirbas, Mark Gordon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 20, 2013
Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design
Johannes Koehbach, Margaret O'Brien, Markus Muttenthaler, et al.
Science Signaling
|
December 7, 2017
Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species
Markus Muttenthaler, Åsa Andersson, Irina Vetter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 21, 2016
Restoring immune tolerance in neuromyelitis optica: Part I
Larry Steinman, Amit Bar-Or, Jacinta M Behne, et al.
Microbiology Spectrum
|
December 13, 2022
Portable Differential Detection of CTX-M ESBL Gene Variants, <i>bla</i><sub>CTX-M-1</sub> and <i>bla</i><sub>CTX-M-15</sub>, from Escherichia coli Isolates and Animal Fecal Samples Using Loop-Primer Endonuclease Cleavage Loop-Mediated Isothermal Amplification
Owen Higgins, Alexandra Chueiri, Louise O'Connor, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 21, 2016
Restoring immune tolerance in neuromyelitis optica: Part II
Amit Bar-Or, Larry Steinman, Jacinta M Behne, et al.
The New England Journal of Medicine
|
May 4, 2017
Teprotumumab for Thyroid-Associated Ophthalmopathy
Terry J Smith, George J Kahaly, Daniel G Ezra, et al.
Ophthalmology
|
October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study
Raymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.
The New England Journal of Medicine
|
January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye Disease
Raymond S Douglas, George J Kahaly, Amy Patel, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
|
October 2, 2023
Retinal Changes After Acute and Late Optic Neuritis in Aquaporin-4 Antibody Seropositive NMOSD
Frederike C Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 232) with videos related to
Sort By:
Page
of 24
Archives of Ophthalmology (Chicago, Ill. : 1960)
|
September 16, 2009
Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique
Raymond S Douglas, Angelo Tsirbas, Mark Gordon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 20, 2013
Oxytocic plant cyclotides as templates for peptide G protein-coupled receptor ligand design
Johannes Koehbach, Margaret O'Brien, Markus Muttenthaler, et al.
Science Signaling
|
December 7, 2017
Subtle modifications to oxytocin produce ligands that retain potency and improved selectivity across species
Markus Muttenthaler, Åsa Andersson, Irina Vetter, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 21, 2016
Restoring immune tolerance in neuromyelitis optica: Part I
Larry Steinman, Amit Bar-Or, Jacinta M Behne, et al.
Microbiology Spectrum
|
December 13, 2022
Portable Differential Detection of CTX-M ESBL Gene Variants, <i>bla</i><sub>CTX-M-1</sub> and <i>bla</i><sub>CTX-M-15</sub>, from Escherichia coli Isolates and Animal Fecal Samples Using Loop-Primer Endonuclease Cleavage Loop-Mediated Isothermal Amplification
Owen Higgins, Alexandra Chueiri, Louise O'Connor, et al.
Neurology(R) Neuroimmunology & Neuroinflammation
|
September 21, 2016
Restoring immune tolerance in neuromyelitis optica: Part II
Amit Bar-Or, Larry Steinman, Jacinta M Behne, et al.
The New England Journal of Medicine
|
May 4, 2017
Teprotumumab for Thyroid-Associated Ophthalmopathy
Terry J Smith, George J Kahaly, Daniel G Ezra, et al.
Ophthalmology
|
October 24, 2021
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study
Raymond S Douglas, George J Kahaly, Shoaib Ugradar, et al.
The New England Journal of Medicine
|
January 24, 2020
Teprotumumab for the Treatment of Active Thyroid Eye Disease
Raymond S Douglas, George J Kahaly, Amy Patel, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
|
October 2, 2023
Retinal Changes After Acute and Late Optic Neuritis in Aquaporin-4 Antibody Seropositive NMOSD
Frederike C Oertel, Hanna G Zimmermann, Seyedamirhosein Motamedi, et al.
Page
of 24